Paracrine effects of mir-210-3p on angiogenesis in hypoxia-treated c-kit-positive cardiac cells

References

• Katikireddy CK, Acharya T. Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure. Int J Cardiovasc Imaging. 2019;35(5):1–14. doi: 10.1007/s10554-018-01515-3.
   PubMed Web of Science ®Google Scholar
• Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010;121(2):293–305. doi: 10.1161/CIRCULATIONAHA.109.871905.
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763–776. doi: 10.1016/s0092-8674(03)00687-1.
   PubMed Web of Science ®Google Scholar
• Li Q, Guo Y, Ou Q, et al. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011;106(5):849–864. doi: 10.1007/s00395-011-0180-1.
   PubMed Web of Science ®Google Scholar
• Hong KU, Guo Y, Li QH, et al. c-kit + cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLOS One. 2014;9(5):e96725. doi: 10.1371/journal.pone.0096725.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Mukherjee B, Dixit M. MicroRNA key to angiogenesis regulation: miRNA biology and therapy. Curr Cancer Drug Targets. 2018;18(3):266–277. doi: 10.2174/1568009617666170630142725.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lee CG. MicroRNA and cancer – focus on apoptosis. J Cell Mol Med. 2009;13(1):12–23. doi: 10.1111/j.1582-4934.2008.00510.x.
   PubMed Web of Science ®Google Scholar
• Harris TA, Yamakuchi M, Ferlito M, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008;105(5):1516–1521. doi: 10.1073/pnas.0707493105.
   PubMed Web of Science ®Google Scholar
• Wang J, Huang W, Xu R, et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med. 2012;16(9):2150–2160. doi: 10.1111/j.1582-4934.2012.01523.x.
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA. 2008;105(35):13027–13032. doi: 10.1073/pnas.0805038105.
   PubMed Web of Science ®Google Scholar
• De Gonzalo-Calvo D, Iglesias-Gutiérrez E, Llorente-Cortés V. Epigenetic biomarkers and cardiovascular disease: circulating microRNAs. Rev Esp Cardiol. 2017;70(9):763–769. doi: 10.1016/j.recesp.2017.02.027.
   PubMed Web of Science ®Google Scholar
• Kalayinia S, Arjmand F, Maleki M, et al. MicroRNAs: roles in cardiovascular development and disease. Cardiovasc Pathol. 2021;50:107296. doi: 10.1016/j.carpath.2020.107296.
   PubMed Web of Science ®Google Scholar
• Hu S, Huang M, Li Z, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation. 2010;122(11 Suppl.):S124–S131. doi: 10.1161/CIRCULATIONAHA.109.928424.
   PubMed Web of Science ®Google Scholar
• Sirish P, López JE, Li N, et al. MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J Mol Cell Cardiol. 2012;52(1):264–272. doi: 10.1016/j.yjmcc.2011.10.012.
   PubMed Web of Science ®Google Scholar
• Wang J, Greene SB, Bonilla-Claudio M, et al. Bmp-signaling regulates myocardial differentiation from cardiac progenitors through a microRNA-mediated mechanism. Dev Cell. 2010;19(6):903–912. doi: 10.1016/j.devcel.2010.10.022.
   PubMed Web of Science ®Google Scholar
• Anand S, Majeti BK, Acevedo LM, et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med. 2010;16(8):909–914. doi: 10.1038/nm.2186.
   PubMed Web of Science ®Google Scholar
• Anand S. A brief primer on microRNAs and their roles in angiogenesis. Vasc Cell. 2013;5(1):2. doi: 10.1186/2045-824X-5-2.
   PubMedGoogle Scholar
• Spengler RM, Oakley CK, Davidson BL. Functional microRNAs and target sites are created by lineage-specific transposition. Hum Mol Genet. 2014;23(7):1783–1793. doi: 10.1093/hmg/ddt569.
   PubMed Web of Science ®Google Scholar
• Crouser ED, Hamzeh NY, Maier LA, et al. Exosomal microRNA for detection of cardiac sarcoidosis. Am J Respir Crit Care Med. 2017;196(7):931–934. doi: 10.1164/rccm.201611-2183LE.
   PubMed Web of Science ®Google Scholar
• Xiao K, Thum T. Exosomal microRNAs released by pediatric cardiac progenitor cells. Circ Res. 2017;120(4):607–609. doi: 10.1161/CIRCRESAHA.117.310443.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Tang XL, Li Q, Rokosh G, et al. Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res. 2016;118(7):1091–1105. doi: 10.1161/CIRCRESAHA.115.307647.
   PubMed Web of Science ®Google Scholar
• Bolli R, Tang XL, Sanganalmath SK, et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013;128(2):122–131. doi: 10.1161/CIRCULATIONAHA.112.001075.
   PubMed Web of Science ®Google Scholar
• Bolli R, Tang XL, Guo Y, et al. After the storm: an objective appraisal of the efficacy of c-kit + cardiac progenitor cells in preclinical models of heart disease. Can J Physiol Pharmacol. 2021;99(2):129–139. doi: 10.1139/cjpp-2020-0406.
   PubMed Web of Science ®Google Scholar
• Wang Y, Pan X, Fan Y, et al. Dysregulated expression of microRNAs and mRNAs in myocardial infarction. Am J Transl Res. 2015;7(11):2291–2304.
   PubMed Web of Science ®Google Scholar
• Diao H, Liu B, Shi Y, et al. MicroRNA-210 alleviates oxidative stress-associated cardiomyocyte apoptosis by regulating BNIP3. Biosci Biotechnol Biochem. 2017;81(9):1712–1720. doi: 10.1080/09168451.2017.1343118.
   PubMed Web of Science ®Google Scholar
• Kulshreshtha R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia. Mol Cell Biol. 2007;27(5):1859–1867. doi: 10.1128/MCB.01395-06.
   PubMed Web of Science ®Google Scholar
• Chan SY, Zhang YY, Hemann C, et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron–sulfur cluster assembly proteins ISCU1/2. Cell Metab. 2009;10(4):273–284. doi: 10.1016/j.cmet.2009.08.015.
   PubMed Web of Science ®Google Scholar
• Huang X, Le QT, Giaccia AJ. MiR-210 – micromanager of the hypoxia pathway. Trends Mol Med. 2010;16(5):230–237. doi: 10.1016/j.molmed.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Bolli R, Hare JM, March KL, et al. Rationale and design of the CONCERT-HF trial (combination of mesenchymal and c-kit(+) cardiac stem cells as regenerative therapy for heart failure). Circ Res. 2018;122(12):1703–1715. doi: 10.1161/CIRCRESAHA.118.312978.
   PubMed Web of Science ®Google Scholar
• Dawas K, Loizidou M, Shankar A, et al. Angiogenesis in cancer: the role of endothelin-1. Ann R Coll Surg Engl. 1999;81(5):306–310.
   PubMed Web of Science ®Google Scholar
• Mo FE, Muntean AG, Chen CC, et al. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol. 2002;22(24):8709–8720. doi: 10.1128/MCB.22.24.8709-8720.2002.
   PubMed Web of Science ®Google Scholar
• Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12(7):676–685. doi: 10.1038/ncb2070.
   PubMed Web of Science ®Google Scholar
• Amann K, Faulhaber J, Campean V, et al. Impaired myocardial capillarogenesis and increased adaptive capillary growth in FGF2-deficient mice. Lab Invest. 2006;86(1):45–53. doi: 10.1038/labinvest.3700359.
   PubMed Web of Science ®Google Scholar
• Wu M, Claus P, Vanden Driessche N, et al. Placental growth factor 2 – a potential therapeutic strategy for chronic myocardial ischemia. Int J Cardiol. 2016;203:534–542. doi: 10.1016/j.ijcard.2015.10.177.
   PubMed Web of Science ®Google Scholar
• Fang Y, Shen J, Yao M, et al. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. Br J Dermatol. 2010;162(3):478–486. doi: 10.1111/j.1365-2133.2009.09528.x.
   PubMed Web of Science ®Google Scholar
• Mann A, Niekisch K, Schirmacher P, et al. Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing. J Investig Dermatol Symp Proc. 2006;11(1):87–92. doi: 10.1038/sj.jidsymp.5650013.
   PubMedGoogle Scholar
• RajendranNair DS, Karunakaran J, Nair RR. Sub-physiological oxygen levels optimal for growth and survival of human atrial cardiac stem cells. Mol Cell Biochem. 2017;432(1–2):109–122. doi: 10.1007/s11010-017-3002-4.
   PubMed Web of Science ®Google Scholar
• Bao L, Meng Q, Li Y, et al. C-kit positive cardiac stem cells and bone marrow-derived mesenchymal stem cells synergistically enhance angiogenesis and improve cardiac function after myocardial infarction in a paracrine manner. J Card Fail. 2017;23(5):403–415. doi: 10.1016/j.cardfail.2017.03.002.
   PubMed Web of Science ®Google Scholar